Strategies of neuroprotection for intracranial aneurysms

Thomas Frietsch, Jeffrey Kirsch

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Neuroprotection for patients with intracranial aneurysms encompasses the preservation of brain cells endangered by a limited blood and oxygen supply due to aneurysm rupture, clipping or coiling, as well as vasospasm. A large variety of prophylactic and therapeutic neuroprotective strategies have been proposed, but success in human disease is quite limited. Topics of this chapter are the pathophysiology and treatment options of aneurysms, as well as promising neuroprotective strategies in further developmental stages: both physiologically based (hyperoxygenation, hypothermia, avoidance of hyperthermia and hyperglycaemia, hypertension, haemodilution and hypervolaemia) and pharmacologically based (antifibrinolytic drugs, calcium antagonists, anaesthetics, magnesium, erythropoietin and others). New concepts are ischaemic preconditioning, growth factors, and gene therapy. Each strategy is rated on underlying evidence, and research agendas are mentioned.

Original languageEnglish (US)
Pages (from-to)595-630
Number of pages36
JournalBest Practice and Research: Clinical Anaesthesiology
Volume18
Issue number4
DOIs
StatePublished - Dec 2004

Fingerprint

Intracranial Aneurysm
Aneurysm
Ischemic Preconditioning
Antifibrinolytic Agents
Hemodilution
Erythropoietin
Hypothermia
Hyperglycemia
Genetic Therapy
Magnesium
Anesthetics
Rupture
Intercellular Signaling Peptides and Proteins
Fever
Oxygen
Hypertension
Calcium
Brain
Therapeutics
Research

Keywords

  • Anaesthetics
  • Calcium antagonists
  • Endovascular coiling
  • Erythropoietin
  • Evidence-based medicine
  • Ischaemic preconditioning
  • Neurosurgical clipping
  • Triple H

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Psychology(all)

Cite this

Strategies of neuroprotection for intracranial aneurysms. / Frietsch, Thomas; Kirsch, Jeffrey.

In: Best Practice and Research: Clinical Anaesthesiology, Vol. 18, No. 4, 12.2004, p. 595-630.

Research output: Contribution to journalArticle

@article{f9f9fea33b194f7db645c28c27a16073,
title = "Strategies of neuroprotection for intracranial aneurysms",
abstract = "Neuroprotection for patients with intracranial aneurysms encompasses the preservation of brain cells endangered by a limited blood and oxygen supply due to aneurysm rupture, clipping or coiling, as well as vasospasm. A large variety of prophylactic and therapeutic neuroprotective strategies have been proposed, but success in human disease is quite limited. Topics of this chapter are the pathophysiology and treatment options of aneurysms, as well as promising neuroprotective strategies in further developmental stages: both physiologically based (hyperoxygenation, hypothermia, avoidance of hyperthermia and hyperglycaemia, hypertension, haemodilution and hypervolaemia) and pharmacologically based (antifibrinolytic drugs, calcium antagonists, anaesthetics, magnesium, erythropoietin and others). New concepts are ischaemic preconditioning, growth factors, and gene therapy. Each strategy is rated on underlying evidence, and research agendas are mentioned.",
keywords = "Anaesthetics, Calcium antagonists, Endovascular coiling, Erythropoietin, Evidence-based medicine, Ischaemic preconditioning, Neurosurgical clipping, Triple H",
author = "Thomas Frietsch and Jeffrey Kirsch",
year = "2004",
month = "12",
doi = "10.1016/j.bpa.2004.05.001",
language = "English (US)",
volume = "18",
pages = "595--630",
journal = "Bailliere's Best Practice and Research in Clinical Anaesthesiology",
issn = "1521-6896",
publisher = "Bailliere Tindall Ltd",
number = "4",

}

TY - JOUR

T1 - Strategies of neuroprotection for intracranial aneurysms

AU - Frietsch, Thomas

AU - Kirsch, Jeffrey

PY - 2004/12

Y1 - 2004/12

N2 - Neuroprotection for patients with intracranial aneurysms encompasses the preservation of brain cells endangered by a limited blood and oxygen supply due to aneurysm rupture, clipping or coiling, as well as vasospasm. A large variety of prophylactic and therapeutic neuroprotective strategies have been proposed, but success in human disease is quite limited. Topics of this chapter are the pathophysiology and treatment options of aneurysms, as well as promising neuroprotective strategies in further developmental stages: both physiologically based (hyperoxygenation, hypothermia, avoidance of hyperthermia and hyperglycaemia, hypertension, haemodilution and hypervolaemia) and pharmacologically based (antifibrinolytic drugs, calcium antagonists, anaesthetics, magnesium, erythropoietin and others). New concepts are ischaemic preconditioning, growth factors, and gene therapy. Each strategy is rated on underlying evidence, and research agendas are mentioned.

AB - Neuroprotection for patients with intracranial aneurysms encompasses the preservation of brain cells endangered by a limited blood and oxygen supply due to aneurysm rupture, clipping or coiling, as well as vasospasm. A large variety of prophylactic and therapeutic neuroprotective strategies have been proposed, but success in human disease is quite limited. Topics of this chapter are the pathophysiology and treatment options of aneurysms, as well as promising neuroprotective strategies in further developmental stages: both physiologically based (hyperoxygenation, hypothermia, avoidance of hyperthermia and hyperglycaemia, hypertension, haemodilution and hypervolaemia) and pharmacologically based (antifibrinolytic drugs, calcium antagonists, anaesthetics, magnesium, erythropoietin and others). New concepts are ischaemic preconditioning, growth factors, and gene therapy. Each strategy is rated on underlying evidence, and research agendas are mentioned.

KW - Anaesthetics

KW - Calcium antagonists

KW - Endovascular coiling

KW - Erythropoietin

KW - Evidence-based medicine

KW - Ischaemic preconditioning

KW - Neurosurgical clipping

KW - Triple H

UR - http://www.scopus.com/inward/record.url?scp=4344625648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344625648&partnerID=8YFLogxK

U2 - 10.1016/j.bpa.2004.05.001

DO - 10.1016/j.bpa.2004.05.001

M3 - Article

C2 - 15460548

AN - SCOPUS:4344625648

VL - 18

SP - 595

EP - 630

JO - Bailliere's Best Practice and Research in Clinical Anaesthesiology

JF - Bailliere's Best Practice and Research in Clinical Anaesthesiology

SN - 1521-6896

IS - 4

ER -